论文信息 - Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial. - 字舞流文

Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial.

G. Scagliotti | C. Gridelli | M. Rinaldi | F. de Marinis | L. Crinò | M. Tonato | M. Noseda | G. Selvaggi | C. Calandri | A. Mosconi | M. Della Giulia